低氧驱动的代谢和分子重编程:从瘤微环境到治疗干预
Diksha Devi1, Kanchan Sharma2, Tabish Khan3
1L.R. Institute of Pharmacy, Jabli-kyar, Oachaghat, Solan, Himachal Pradesh, India.
Pathology, research and practice
|October 17, 2025
概括
缺氧,或低氧,通过改变细胞代谢和促进瘤入侵,驱动癌症的生长和扩散. 了解这些缺氧诱导因素 (HIF) 是改善癌症治疗策略的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症新陈代谢 癌症新陈代谢
背景情况:
- 缺氧 (氧气减少) 是癌症进展的一个关键因素.
- 它影响瘤的生长,扩散和对治疗的抗性.
- 缺氧诱导因素 (HIF) 调节了参与癌症发展的关键基因.
研究的目的:
- 研究瘤生物学中缺氧的基本机制.
- 在低氧条件下阐明HIFs在癌症进展中的作用.
- 审查缺氧如何影响血管生成,新陈代谢和治疗抵抗.
主要方法:
- 文献综述侧重于分子和代谢适应缺氧的情况.
- 通过HIF-1α和HIF-2α对基因调节的分析.
- 检查缺氧对表皮细胞转移到介质细胞 (EMT) 和血管生成 (VEGF) 的影响.
主要成果:
- 缺氧通过HIF激活促进癌细胞存活,入侵和转移.
- 受影响的关键过程包括EMT,增加血管生成 (VEGF) 和代谢重编程 (糖解).
- 这些适应性有助于低氧瘤的治疗耐药性.
结论:
- 缺氧是瘤进展和治疗耐药性的核心驱动因素.
- 准缺氧介导途径为癌症治疗提供了一个有希望的策略.
- 进一步研究缺氧下代谢和分子机制的相互作用至关重要.
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Hypoxia
1.9K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.9K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K


